Skip to content
10-Q

Quarterly Report

CEN BIOTECH, INC.

0001437749-22-021119

← back to feed
Filed
Aug 22, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 22, 2022 61.8M sh
Stock Issued Q2 2022 · Jun 30, 2022 33K sh
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$421.11K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$277.46K
Short Term Debt Q2 2022 · Jun 30, 2022 $1.69M
Short Term Debt Q2 2022 · Dec 31, 2021 $1.69M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $66.05K
Cash And Equivalents Q2 2022 · Dec 31, 2021 $193.2K
Stockholders Equity Q2 2022 · Jun 30, 2022 −$1.86M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$1.92M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$1.66M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$10.46M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$9.99M
Current Liabilities Q2 2022 · Jun 30, 2022 $9.73M
Current Liabilities Q2 2022 · Dec 31, 2021 $9.86M
Total Liabilities Q2 2022 · Jun 30, 2022 $9.93M
Total Liabilities Q2 2022 · Dec 31, 2021 $10.1M
Current Assets Q2 2022 · Jun 30, 2022 $245.13K
Current Assets Q2 2022 · Dec 31, 2021 $472.22K
Total Assets Q2 2022 · Jun 30, 2022 $8.07M
Total Assets Q2 2022 · Dec 31, 2021 $8.44M
Eps Basic Q2 2022 · Jun 30, 2022 $0.00
Eps Basic Q2 2022 · Jun 30, 2022 $0.00
Eps Basic Q2 2022 · Jun 30, 2021 −$0.06
Eps Basic Q2 2022 · Jun 30, 2021 −$0.11
Eps Basic Q2 2022 · Dec 31, 2020 $0.00
Sga Expense Q2 2022 · Jun 30, 2022 $693.61K
Sga Expense Q2 2022 · Jun 30, 2022 $1.13M
Sga Expense Q2 2022 · Jun 30, 2021 $394.21K
Sga Expense Q2 2022 · Jun 30, 2021 $632.1K
Net Income Q2 2022 · Jun 30, 2022 −$348.28K
Net Income Q2 2022 · Jun 30, 2022 −$607.15K
Net Income Q2 2022 · Mar 31, 2022 −$258.87K
Net Income Q2 2022 · Jun 30, 2021 −$15.49M
Net Income Q2 2022 · Jun 30, 2021 −$16.12M
Net Income Q2 2022 · Mar 31, 2021 −$623.04K
Operating Income Q2 2022 · Jun 30, 2022 −$299.97K
Operating Income Q2 2022 · Jun 30, 2022 −$439.85K
Operating Income Q2 2022 · Jun 30, 2021 −$16.26M
Operating Income Q2 2022 · Jun 30, 2021 −$16.61M
Revenue Q2 2022 · Jun 30, 2022 $542.48K
Revenue Q2 2022 · Jun 30, 2022 $882.74K
Shares Diluted Q2 2022 · Dec 31, 2020 61.34M sh
Eps Diluted Q2 2022 · Dec 31, 2020 $0.00